Martingale Asset Management L P Pmv Pharmaceuticals, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.01 - $8.93 $48,080 - $71,440	8,000 Added 37.57%	29,296 $179,000
Q2 2023 Aug 11, 2023	BUY	$3.94 - $6.27 $78 - $125	20 Added 0.09%	21,296 $133,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $17.18 $17,031 - $25,666	1,494 Added 7.55%	21,276 $254,000
Q2 2022 Aug 11, 2022	BUY	$9.23 - $22.43 $182,587 - $443,710	19,782 New	19,782 $281,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.